Diabetes Insipidus and Concomitant Myocarditis: A Late Sequelae of COVID-19 Infection

J Investig Med High Impact Case Rep. 2021 Jan-Dec:9:2324709621999954. doi: 10.1177/2324709621999954.

Abstract

Severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019 (COVID-19), which has become a global pandemic. Apart from the mild features of the disease, long-term complications involve many systems including both endocrine and cardiovascular systems. Myocarditis, secondary to COVID-19, has become a well-known complication of the disease. However, endocrine complications are generally not common, particularly isolated pituitary abnormalities. There is one other report of diabetes insipidus developing as a late sequela of COVID-19. In this article, we report a case of a young male who presented with features of myocarditis but developed diabetes insipidus on day 7 of admission as a long-term complication after recovery from COVID-19 infection. His laboratory test results at the time of developing the complication revealed a high serum sodium level and low urine osmolality. The patient recovered on administration of desmopressin and was discharged after 16 days of hospitalization.

Keywords: COVID-19; complication; diabetes insipidus; myocarditis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • COVID-19 / complications*
  • COVID-19 / diagnostic imaging
  • Diabetes Insipidus / etiology*
  • Humans
  • Lung / diagnostic imaging
  • Lung / pathology
  • Male
  • Myocarditis / virology*
  • Osmolar Concentration
  • Sodium / blood
  • Tomography, X-Ray Computed
  • Urine / chemistry

Substances

  • Sodium